PROTECT MULTI AKTIENANLEIHE - BAYER/MERCK/BASF Stock

Certificat

DE000VM4YSV8

Delayed Deutsche Boerse AG 11:03:34 2024-05-21 EDT
98.1 EUR -0.52% Intraday chart for PROTECT MULTI AKTIENANLEIHE - BAYER/MERCK/BASF
Current month+1.82%
1 month+4.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 98.1 -0.52%
24-05-20 98.61 +0.47%
24-05-17 98.15 +0.09%
24-05-16 98.06 -0.08%
24-05-15 98.14 +0.36%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 11:03 am

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Vontobel Vontobel
WKN VM4YSV
ISINDE000VM4YSV8
Date issued 2023-11-20
Strike 161
Maturity 2024-09-20 (122 Days)
Parity 0.16 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 100
Lowest since issue 92.07
Spread 5
Spread %0.51%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
166.6 EUR
Average target price
182.3 EUR
Spread / Average Target
+9.46%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW